In The News Posted January 10, 2020 Share Posted January 10, 2020 SAN MATEO, Calif., Jan. 10, 2020 /PRNewswire/ -- Rakuten Medical, Inc. (RMI) a clinical-stage, global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox™, will present at the 38th Annual J.P. Morgan... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.